None listed
Conditions
Brief summary
People with attention deficit hyperactivity disorder (ADHD) may also have developmental coordination disorder (DCD), which is not always recognised. Individuals with combined ADHD and DCD have increased likelihood of developing anxiety and depression. Evidence detailing early identification and treatment is limited. This project aims to characterise a screening pathway for children with ADHD to diagnose DCD. It will use an established DCD treatment, the cognitive orientation to daily occupational performance (CO-OP) approach, to see if the mental health of those with both ADHD and DCD improves. There will be two linked studies, with children identified with DCD in the first study invited to participate in the second.
Interventions
This project consists of two linked studies Study A; Diagnostic profiling for developmental coordination disorder in 8-12 year old children with attention deficit hyperactivity disorder, and Study B; Developmental coordination disorder, attention deficit hyperactivity disorder and the cognitive orientation to daily occupational performance approach: Is there a role for improving mental health outcomes? Materials Used: pencils, pens, paper, assessment booklets (BOT-2 - readily available), informational/educational handouts re: DCD (from CanChild website - readily available), testing equipment (BOT-2 - readily available), intervention equipment pertaining directly to client chosen goal. Procedures Used: Study A consists of a clinical interview and x2 assessments being conducted. Study B consists of an established intervention, the Cognitive Orientation to daily Occupational Performance (CO-OP) Approach being applied. CO-OP is a strategy-based problem-solving method of teaching and improving functional motor skills in 7-12 year olds. It typically runs over a 10 week period, although this can be slightly shorter or longer if required. Intervention Delivery: Leiemma Canty, Occupational Therapist with 24 years clinical experience and is the postgraduate student researcher. Mode of Delivery: face to face one-to-one sessions and phone calls. Intervention Dosage: Study A will require a maximum of 2 hours per participant, with two face to face sessions to i) discuss project and ii) complete screening assessments and brief phone contact before and after sessions. Study B will involve a maximum of a 25 hour time commitment per participant, spread across a 24-28 week period, with participants seen up to 15 times, for 30-60 minute sessions. Sessions in Study B will be held in week 1, then weeks 5-17/20, then x1/mth for a further 2 months. A subset of participants from Study A will be invited to participate in Study B ie. if they are diagnosed with DCD, up to the first 10 to accept will participate in Study B. Location: private practice clinic of postgraduate researcher, Invermay Allied Health. Fidelity: the CO-OP Approach fidelity checklist will be completed by the postgraduate investigator for each participant at each face-to-face intervention session in Study B.
Sponsors
Study design
Eligibility
Inclusion criteria
Inclusion criteria: - aged between 8-12 years - must have a pre-existing diagnosis of ADHD - current pharmacotherapy treatment for ADHD - current Paediatrician - if CO-OP is used in Study B with a participant also diagnosed with DCD in Study A, an additional inclusion criteria applies for cognition (have adequate cognitive ability to participate in the intervention program (the child can attend and understand the strategies to be used in the CO-OP Approach).
Exclusion criteria
Exclusion criteria: - clients without a pre-existing diagnosis of ADHD - pre-exisiting motor disorder (as precludes a potential diagnosis of DCD) - identified intellectual disability - clients with ADHD currently unmedicated - clients outside of Northern Tasmania - cannot proceed to Study B if criteria for DCD not met in Study A.